Plaque Psoriasis Market Size is Predicted to See Upsurge Through 2034, Highlights DelveInsight

DelveInsight's "Plaque Psoriasis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Plaque Psoriasis, historical and forecasted epidemiology as well as the Plaque Psoriasis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Plaque Psoriasis market outlook, drug uptake, treatment scenario @ https://www.delveinsight.com/sample-request/plaque-psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Some of the key facts of the Plaque Psoriasis Market Report:
• The Plaque Psoriasis market size is estimated to grow with a significant CAGR during the study period (2020-2034)
• Plaque Psoriasis affected women more than it did men, according to DelveInsight's data. For example, in Japan in 2021, there were about 34,000 cases of Plaque Psoriasis in males and about 39,000 in females.
• The Plaque Psoriasis epidemiology based on gender analyzed that the prevalence of moderate cases is the highest, followed by severe and mild cases
• The Plaque Psoriasis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Plaque Psoriasis pipeline products will significantly revolutionize the Plaque Psoriasis market dynamics.
• The leading Plaque Psoriasis Companies such as Dermavant Sciences GmbH, IQVIA Biotech, UCB Biopharma SRL, Parexel, Samsung Bioepis Co., Ltd, Durect, Astellas, Biogen, Dow Pharmaceutical Sciences, Shire, Zalicus, AbbVie, Santalis Pharmaceuticals Inc, Maruho Co Ltd, Novartis, AstraZeneca, Pfizer, and others
• Promising Plaque Psoriasis Therapies such as AX-158, tapinarof cream, 1%, TAK-279, TQH3906 capsules, Apremilast, Cetaphil, LY3972406, GNR-068, D-2570, ZL-1102, ESK-001, Deucravacitinib, JNJ-77242113, and others

Plaque Psoriasis Overview
Plaque psoriasis is a chronic autoimmune skin condition characterized by the rapid buildup of skin cells, leading to the formation of thick, red, scaly patches, or plaques. These plaques often appear on the scalp, elbows, knees, and lower back, and may cause itching, discomfort, and inflammation. The condition is caused by an overactive immune system, which accelerates skin cell production. While the exact cause is unclear, genetics and environmental factors play a role. Plaque psoriasis is a lifelong condition, but its symptoms can be managed with treatments like topical therapies, phototherapy, and systemic medications.

Get a Free sample for the Plaque Psoriasis Market Report @ https://www.delveinsight.com/sample-request/plaque-psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Plaque Psoriasis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Plaque Psoriasis Epidemiology Segmentation:
The Plaque Psoriasis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Plaque Psoriasis
• Prevalent Cases of Plaque Psoriasis by severity
• Gender-specific Prevalence of Plaque Psoriasis
• Diagnosed Cases of Episodic and Chronic Plaque Psoriasis

Download the report to understand which factors are driving Plaque Psoriasis epidemiology trends @ https://www.delveinsight.com/sample-request/plaque-psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Plaque Psoriasis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Plaque Psoriasis market or expected to get launched during the study period. The analysis covers Plaque Psoriasis market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share. The report also covers the Plaque Psoriasis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Plaque Psoriasis Therapies and Key Companies
• AX-158: Artax Biopharma Inc
• tapinarof cream, 1%: Dermavant Sciences, Inc.
• TAK-279: Takeda
• TQH3906 capsules: Chia Tai Tianqing Pharmaceutical
• Apremilast: Amgen
• Cetaphil: Galderma R&D
• LY3972406: Eli Lilly and Company
• GNR-068: AO GENERIUM
• D-2570: InventisBio Co., Ltd
• ZL-1102: Zai Lab
• ESK-001: Alumis Inc
• Deucravacitinib: Bristol-Myers Squibb
• JNJ-77242113: Janssen Research & Development

Discover more about therapies set to grab major Plaque Psoriasis market share @ https://www.delveinsight.com/sample-request/plaque-psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Plaque Psoriasis Market Strengths
• Increased prevalence, growth in awareness, and lifestyle changes have necessitated changes in the diagnosis and treatment of PsA in the recent decade
• Various screening tools, including self-administered questionnaires, have been developed to help dermatologists, rheumatologist, and general physicians to identify patients who might suffer from PsA

Plaque Psoriasis Market Unmet Needs
• Lack of biomarkers
• Challenges in current treatment options
• Challenges in current guidelines
• Poor disease understanding
• Challenges in managing comorbidities

Scope of the Plaque Psoriasis Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Plaque Psoriasis Companies: Dermavant Sciences GmbH, IQVIA Biotech, UCB Biopharma SRL, Parexel, Samsung Bioepis Co., Ltd, Durect, Astellas, Biogen, Dow Pharmaceutical Sciences, Shire, Zalicus, AbbVie, Santalis Pharmaceuticals Inc, Maruho Co Ltd, Novartis, AstraZeneca, Pfizer, and others
• Plaque Psoriasis Therapies: AX-158, tapinarof cream, 1%, TAK-279, TQH3906 capsules, Apremilast, Cetaphil, LY3972406, GNR-068, D-2570, ZL-1102, ESK-001, Deucravacitinib, JNJ-77242113, and others
• Plaque Psoriasis Therapeutic Assessment: Plaque Psoriasis current marketed and Plaque Psoriasis emerging therapies
• Plaque Psoriasis Market Dynamics: Plaque Psoriasis market drivers and Plaque Psoriasis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Plaque Psoriasis Unmet Needs, KOL's views, Analyst's views, Plaque Psoriasis Market Access and Reimbursement

To know more about Plaque Psoriasis companies working in the treatment market, visit @ https://www.delveinsight.com/sample-request/plaque-psoriasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Plaque Psoriasis Market Report Introduction
2. Executive Summary for Plaque Psoriasis
3. SWOT analysis of Plaque Psoriasis
4. Plaque Psoriasis Patient Share (%) Overview at a Glance
5. Plaque Psoriasis Market Overview at a Glance
6. Plaque Psoriasis Disease Background and Overview
7. Plaque Psoriasis Epidemiology and Patient Population
8. Country-Specific Patient Population of Plaque Psoriasis
9. Plaque Psoriasis Current Treatment and Medical Practices
10. Plaque Psoriasis Unmet Needs
11. Plaque Psoriasis Emerging Therapies
12. Plaque Psoriasis Market Outlook
13. Country-Wise Plaque Psoriasis Market Analysis (2019-2032)
14. Plaque Psoriasis Market Access and Reimbursement of Therapies
15. Plaque Psoriasis Market Drivers
16. Plaque Psoriasis Market Barriers
17. Plaque Psoriasis Appendix
18. Plaque Psoriasis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.